Regeneron Pharmaceuticals Inc.
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
Regeneron Pharmaceuticals Inc. has 3 disclosed EU lobbying meetings from 2026-01-21 to 2026-06-16: 0 with the European Commission and 3 with Members of the European Parliament. Source: EU Transparency Register no. 045767293922-02, Commission disclosures and MEP declarations.
Lobbying profile
as declared 2026-04-07- Category
- Companies & groups
- Legal status
- Corporation
- Declared lobbying cost
- €100,000
- Lobbying FTEs
- 0.25
- Members
- 1
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Declared fields of interest
Business and industry · Competition · Customs · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · Institutional affairs · Public health · Research and innovation · Single market · Taxation
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
Frequently asked
How many EU lobbying meetings has Regeneron Pharmaceuticals Inc. disclosed?
Regeneron Pharmaceuticals Inc. (EU Transparency Register no. 045767293922-02) appears in 3 disclosed meetings with EU officials and MEPs between 2026-01-21 and 2026-06-16: 0 with the European Commission and 3 with Members of the European Parliament.
What does Regeneron Pharmaceuticals Inc. lobby on?
Regeneron Pharmaceuticals Inc.'s disclosed EU meetings most often concern Biotech Act, Biotech I, Skin diseases. Every meeting and its topic is listed with its official source on this page.
Who does Regeneron Pharmaceuticals Inc. meet in Brussels?
Across its disclosed meetings, Regeneron Pharmaceuticals Inc. has met MEPs including KULJA András Tivadar, KULMUNI Katri, PIETIKÄINEN Sirpa. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with Regeneron Pharmaceuticals Inc. — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.